Glomerular Disease Therapeutics Market Analysis and Size
Market Definition
Glomerular disease is a type of renal disorder affecting the small filtering unit of kidneys called glomeruli. It is caused by autoimmune disorders, genetic factors, infections in other parts of the body, and sclerotic diseases.
Overview
The global glomerular disease therapeutics market is expected to witness significant growth during the forecast period. The growth is attributed to the rise in cases of kidney disorders worldwide and a vulnerable aging population. Ongoing research activities related to glomerular disease therapeutics, high patient awareness levels, and a favorable regulatory scenario are considered positive indicators for market growth.
Key Market Insights:
- Forecast Period: 2022 to 2029
- Expected CAGR: Around 5%
- Market Value (2021): USD 12,590.4 million
- Projected Market Value (2029): USD 18,601.7 million
- Market Scope and Segmentation
Browse Full Report Along with Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-glomerular-disease-therapeutics-market
Report Metric Details:
- Indication: Glomerulonephritis, Nephropathy, Goodpasture Syndrome, Others
- Treatment: Corticosteroids, ACE Inhibitors, Immunosuppressive Therapy, Others
- Route of Administration: Oral, Parenteral
- End-Users: Hospitals, Homecare, Specialty Clinics, Others
- Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Geographical Coverage:
- North America: U.S., Canada, Mexico
- Europe: Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe
- Asia-Pacific: China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of APAC
- Middle East and Africa: Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of MEA
- South America: Brazil, Argentina, Rest of South America
Market Players:
- Pfizer Inc (U.S.)
- AstraZeneca (U.K.)
- Bristol-Myers Squibb Company (U.S.)
- Inc (U.S.)
- Reddy's Laboratories Ltd (India)
- Endo International plc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Lupin (India)
- Cipla Inc (India)
- Aurobindo Pharma (India)
- Fresenius SE & Co. KGaA (Germany)
- Sanofi (France)
- Takeda Pharmaceutical Company Limited (Japan)
- Hoffmann-La Roche Ltd (Switzerland)
- Alkem Labs Ltd (India)
- Apotex Inc (Canada)
- WOCKHARDT (India)
Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-glomerular-disease-therapeutics-market
TABLE OF CONTENTS:
- Part 01: Executive Summary
- Part 02: Scope of the Report
- Part 03: Research Methodology
- Part 04: Market Landscape
- Part 05: Pipeline Analysis
- Part 06: Market Sizing
Continue………
Regional Analysis
- Asia-Pacific: Highest growth due to increased smoking, hypertension & diabetic population, and the presence of key manufacturers.
- North America: Dominates the market due to growing cases of kidney disorders and sophisticated medical facilities.
Competitive Landscape
Key players operating in the global glomerular disease therapeutics market include Pfizer Inc, AstraZeneca, AbbVie.Inc, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Novartis AG, Lupin, Cipla Inc, Aurobindo Pharma, Fresenius SE & Co. KGaA, Sanofi, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Alkem Labs Ltd, Apotex Inc, and WOCKHARDT.
Browse Trending Reports:
- Global Emphysema Market
- Global Fibroblast Activation Protein Inhibitors Market
- Global Diuretic Drugs Market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: – sopan.gedam@databridgemarketresearch.com
